New Zealand markets closed

Plus Therapeutics, Inc. (PSTV)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6900+0.0300 (+1.81%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
303
Operating expenses
Research development
9,690
9,690
9,698
5,573
3,481
Selling general and administrative
8,544
8,544
10,238
6,853
6,406
Total operating expenses
13,321
13,321
19,712
12,426
9,887
Operating income or loss
-13,321
-13,321
-19,712
-12,426
-9,584
Interest expense
395
395
711
932
1,107
Total other income/expenses net
-
-
1
-60
2,400
Income before tax
-13,316
-13,316
-20,275
-13,399
-8,241
Income from continuing operations
-13,316
-13,316
-20,275
-13,399
-8,241
Net income
-13,316
-13,316
-20,275
-13,399
-8,241
Net income available to common shareholders
-13,316
-13,316
-20,275
-13,399
-8,241
Basic EPS
-5.87
-4.24
-11.58
-16.65
-27.90
Diluted EPS
-5.87
-4.24
-11.58
-16.65
-27.90
Basic average shares
2,577
3,141
1,750
805.945
295.189
Diluted average shares
2,577
3,141
1,750
805.945
295.189